AMH and non-Hodgkin lymphoma: When analyzed by diagnosis, baseline AMH was decreased in patients with SR/IR-ALL (-0.45 SDS; IQR -0.85 to 0.06) but not in those with HR-ALL (-0.35 SDS; IQR -0.74 to 0.17) or NHL (-0.61 SDS; IQR -1.16 to -0.07) (Figure 3A).